Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Vanda Pharmaceuticals is a small drugmaker that sells prescription medicines for sleep problems, mental health conditions, and multiple sclerosis.
Vanda Pharmaceuticals is a small specialty drugmaker. It sells a handful of prescription medicines, mostly to treat sleep disorders and mental health conditions, and a newer drug for a nerve disease tied to multiple sclerosis. It doesn't discover brand-new molecules from scratch; instead it takes existing drugs, finds new uses for them, and builds a business around the ones it can protect with patents.

Its best-known product is a sleep drug it markets as Hetlioz, for a rare condition where a person's body clock is out of step with the normal day-night schedule. It also sells a drug for a severe movement disorder and, more recently, a treatment for a nerve condition that causes tingling and numbness in people with multiple sclerosis. Vanda sells these through its own small sales force to doctors and patients in the United States and Europe. What makes Vanda unusual is how much of its story is legal rather than medical. Most of its revenue comes from a few drugs facing little or no competition, so it spends heavily on patent fights and lawsuits to keep cheaper generics off the market. Those battles are the real driver of the business: win them and the cash keeps flowing, lose them and the money dries up quickly.
That makes Vanda a high-stakes bet rather than a steady compounder. It spends a lot on research and legal costs, and its fortunes swing on court rulings and regulatory decisions as much as on how well its medicines actually work. It is a tiny player in an industry full of giants, which means headline risk is real and the stock can move sharply on a single verdict.
Saved answer · last researched 16 Nov 2026